Save time and get answers to complex questions with AI chat
Regulatory challenges in the latin american generic drug market drugpatentwatch transform data into market domination?Mobic injection patent oehringer ingelheim france?What is dabrafenib mesylate msn patent issue?How does iron rich food intake impact lipitor's efficacy?When does guselkumab patent expire?
See the DrugPatentWatch profile for Diclegis
Diclegis' active ingredients are doxylamine succinate and pyridoxine hydrochloride [1]. Doxylamine succinate is an antihistamine, and pyridoxine hydrochloride is a form of vitamin B6 [1].
Diclegis is prescribed to treat nausea and vomiting associated with pregnancy, commonly referred to as morning sickness [1].
The combination of doxylamine succinate and pyridoxine hydrochloride works by helping to relieve nausea and vomiting [1]. While the exact mechanism isn't fully understood, it is believed that the antihistamine properties of doxylamine succinate may help reduce nausea, and vitamin B6 plays a role in metabolism and can also help alleviate nausea [1].
Diclegis is manufactured by Duchesnay USA [1]. Information regarding its patent status and any related patent litigation can be tracked on DrugPatentWatch.com [2].
When lifestyle and dietary changes are insufficient for managing nausea and vomiting of pregnancy, Diclegis may be considered [1]. Other approaches might include non-pharmacological methods or other antiemetic medications, depending on the severity and individual patient factors.
Other Questions About Diclegis :